Advertisement

Necrotizing Fasciitis: Flesh Eating Follies

  • Colin G. KaideEmail author
Chapter

Abstract

Necrotizing fasciitis (NF) is an uncommon but not rare diagnosis. It develops along a spectrum often initially looking like cellulitis. The ability to correctly make the diagnosis depends on when the patient presents. Early on it may look like cellulitis, but as it progresses, pain out of proportion to exam findings and a sick-looking patient with rapidly progressing disease should lead the practitioner to strongly consider NF. It is usually a polymicrobial infection; however, monomicrobial (usually Streptococcus pyogenes) infection can happen in healthy, otherwise normal individuals. Treatment is, first and foremost, surgical debridement. Antibiotics, while important, are not effective without timely and aggressive surgical intervention. Hyperbaric oxygen therapy may play an adjunctive role.

Keywords

Streptococcus pyogenes Polymicrobial infection Necrotizing fasciitis Hemorrhagic bullae Hyperbaric oxygen Gas-forming organisms 

Notes

Disclosure Statement

Callibra, Inc.-Discharge 123 medical software company. Medical Advisory Board Portola Pharmaceuticals. I have no relationship with a commercial company that has a direct financial interest in subject matter or materials discussed in article or with a company making a competing product.

References

  1. 1.
    ShiroffAM HGN, Gracias VH. Necrotizing soft tissue infections. J Intensive Care Med. 2014;29(3):138–44.CrossRefGoogle Scholar
  2. 2.
    Jallali WS, Butler PE. Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis. Am J Surg. 2005;189(4):462–6.CrossRefGoogle Scholar
  3. 3.
    Levine EG, Manders SM. Life-threatening necrotizing fasciitis. Clin Dermatol. 2005;23(2):144–7.CrossRefGoogle Scholar
  4. 4.
    Mandell GL, et al. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. New York: Churchill-Livingston; 2005.Google Scholar
  5. 5.
    Brook I, Frazier E. Clinical and microbiological features of necrotizing fasciitis. J Clin Microbiol. 1995;33(9):2382–7.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Hasham S, et al. Necrotising fasciitis. BMJ. 2005;330(7495):830–3.CrossRefGoogle Scholar
  7. 7.
    Sarani B, Strong M, Pascual J, Schwab CW. Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg. 2009;208(2):279–88.CrossRefGoogle Scholar
  8. 8.
    VanUnnik A. Inhibition of toxin production in Clostridium perfringens in vitro by hyperbaric oxygen. Antonie Leeuwenhoek Microbiol. 1965;31:181–6.CrossRefGoogle Scholar
  9. 9.
    Jonsson K, Hunt TK. Oxygen as an isolated variable influences resistance to infection. Ann Surg. 1988;208(6):783–7.CrossRefGoogle Scholar
  10. 10.
    Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am. 2003;85(8):1454–60.CrossRefGoogle Scholar
  11. 11.
    Miller LG, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005;352(14):1445–53.CrossRefGoogle Scholar
  12. 12.
    Lee TC, Carrick MM, Scott BG, Hodges JC, Pham HQ. Incidence and clinical characteristics of methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a large urban hospital. Am J Surg. 2007;194(6):809–12.CrossRefGoogle Scholar
  13. 13.
    Childers BJ, et al. Necrotizing fasciitis: a fourteen-year retrospective study of 163 consecutive patients. Am Surg. 2002;68(2):109–16.PubMedGoogle Scholar
  14. 14.
    Chen JL, Fullerton KE, Flynn NM. Necrotizing fasciitis associated with injection drug use. Clin Infect Dis. 2001;33(1):6–15.CrossRefGoogle Scholar
  15. 15.
    Kuo Chou TN, Chao WN, Yang C, et al. Predictors of mortality in skin and soft-tissue infections caused by Vibrio vulnificus. World J Surg. 2010;34:1669–75.CrossRefGoogle Scholar
  16. 16.
    Chen SC, Chan KS, Chao WN, et al. Clinical outcomes and prognostic factors for patients with Vibrio vulnificus infections requiring intensive care: a 10-yr retrospective study. Crit Care Med. 2010;38:1984–90.CrossRefGoogle Scholar
  17. 17.
    Salcido RS. Necrotizing fasciitis: reviewing the causes and treatment strategies. Adv SkinWound Care. 2007;20:288–93.CrossRefGoogle Scholar
  18. 18.
    Cainzos M, Gonzalez-Rodriguez FJ. Necrotizing soft tissue infections. Curr Opin Crit Care. 2007;13:433–9.CrossRefGoogle Scholar
  19. 19.
    McHenry CR, Piotrowski JJ, Petrinic D, Malangoni MA. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg. 1995;221:558–63; discussion 563–565.CrossRefGoogle Scholar
  20. 20.
    Wong CH, Haw-Chong C, Shanker P, et al. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am. 2003;85:1454–60.CrossRefGoogle Scholar
  21. 21.
    Wall DB, Kleain SR, Black S, de Virgilio C. A simple model to help distinguish necrotizing from non-necrotizing soft tissue infection. J Am Coll Surg. 2000;191(3):227–31.CrossRefGoogle Scholar
  22. 22.
    Wall DB, de Virgilio C, Black S, Klein SR. Objective criteria may assist in distinguishing necrotizing fasciitis from non-necrotizing soft tissue infection. Am J Surg. 2000;179(1):17–21.CrossRefGoogle Scholar
  23. 23.
    Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (Laboratory Risk Indicator for Necrotising Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535–41.CrossRefGoogle Scholar
  24. 24.
    Holland MJ. Application of the Laboratory Risk Indicator in Necrotising Fasciitis (LRINEC) score to patients in a tropical tertiary referral centre. Anaesth Intensive Care. 2009;37(4):588–92.CrossRefGoogle Scholar
  25. 25.
    Wysoki MG, Santora TA, Shah RM, Friedman AC. Necrotizing fasciitis: CT characteristics. Radiology. 1997;203:859–63.CrossRefGoogle Scholar
  26. 26.
    Seok JH, Jee WH, Chun KA, Kim JY, Jung CK, Kim YR, et al. Necrotizing fasciitis versus pyomyositis: discrimination with using MR imaging. Korean J Radiol. 2009;10(2):121–8.CrossRefGoogle Scholar
  27. 27.
    Kim KT, Kim YJ, Won Lee J, Kim YJ, Park SW, Lim MK, et al. Can necrotizing infectious fasciitis be differentiated from nonnecrotizing infectious fasciitis with MR imaging? Radiology. 2011;259(3):816–24.CrossRefGoogle Scholar
  28. 28.
    Andreasen TJ, Green SD, Childers BJ. Massive soft-tissue injury: diagnosis and management of necrotizing fasciitis and purpura fulminans. Plast Reconstr Surg. 2001;107(4):1025–35.CrossRefGoogle Scholar
  29. 29.
    Kelly Bucca K, Spencer R, Orford N, Cattigan C, Athan E, McDonald A. Early diagnosis and treatment of necrotizing fasciitis can improve survival: an observational intensive care unit cohort study. ANZ J Surg. 2013;83:365–70.CrossRefGoogle Scholar
  30. 30.
    Gemmell CG, Peterson PK, Schmeling D, et al. Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin. J Clin Invest. 1981;67(5):1249–56. [Medline]. [Full Text].CrossRefGoogle Scholar
  31. 31.
    Stevens DL, Bryant AE, Yan S. Invasive group a streptococcal infection: new concepts in antibiotic treatment. Int J Antimicrob Agent. 1994;4:297–301.CrossRefGoogle Scholar
  32. 32.
    Kaide CG, Khandelwal S. Hyperbaric oxygen: applications in infectious disease. Emerg Med Clin North Am. 2008;26:571–95, xi.  https://doi.org/10.1016/j.emc.2008.01.005.CrossRefGoogle Scholar
  33. 33.
    Joshua J, Shaw JJ, Psoinos C, Emhoff TA, Shah SA, Santry HP. Not just full of hot air: hyperbaric oxygen therapy increases survival in cases of necrotizing soft tissue infections. Surg Infect. 2014;15(3):328–35.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Emergency Medicine, Wexner Medical Center at The Ohio State UniversityColumbusUSA

Personalised recommendations